Skip to main content

Clinical Trials Using Paclitaxel

Review the clinical trials studying paclitaxel on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 101-125 of 197

Papaverine in Combination with Chemoradiation for the Treatment of Stage II, III, or IV Non-small Cell Lung Cancer
Status: Active
Location: 2 locations
Dupilumab, with Pembrolizumab, Paclitaxel, and Carboplatin for the Treatment of Locally Advanced Triple Negative Breast Cancer
Status: Active
Location: 2 locations
Immunosensitizing Radiation with Neoadjuvant Chemoimmunotherapy for the Treatment of Patients with Stage II-IIIC Borderline Resectable Non-Small Cell Lung Cancer, The NeoRADjuvant Trial
Status: Active
Location: 2 locations
Implantable Microdevice for Evaluating Drug Responses in Patients with Head and Neck Cancers, the Window of Opportunity Study
Status: Active
Location: 2 locations
Paclitaxel before Surgery in Treating Patients with Breast Cancer
Status: Active
Location: 2 locations
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Status: Active
Location: UC San Diego Medical Center - Hillcrest, San Diego, California
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
Status: Active
Location: 2 locations
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Status: Active
Location: 2 locations
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Status: Active
Location: MedStar Washington Hospital Center, Washington, District of Columbia
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York
Perioperative Intraperitoneal Paclitaxel for the Treatment of Stage IV Gastric or Gastroesophageal Adenocarcinoma with Carcinomatosis or Positive Cytology
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Pulsed Dose Chemotherapy Plus Pembrolizumab for First Line Treatment of Recurrent or Metastatic HNSCC
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Chemotherapy with or without HCW9218 before Surgery for the Treatment of Stage III-IV High Grade Serous Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania
Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Gastric Cancer with Limited Peritoneal Metastasis, ROBO-CHIP Study
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
First Line Chemotherapy (Carboplatin and Paclitaxel) and Immunotherapy (Pembrolizumab) for the Treatment of Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma
Status: Active
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy before Surgery for the Treatment of Patients with Breast Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Hyperthermic Intraperitoneal Chemotherapy with Cisplatin and Paclitaxel for the Treatment of Patients with Gastric and Gastroesophageal Junction Adenocarcinoma at High Risk of Peritoneal Recurrence
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Vitamin D Supplementation for the Improvement of Pathologic Complete Response in Vitamin D Deficient Patients Receiving Neoadjuvant Chemotherapy for Operable Triple Negative Breast Cancer
Status: Active
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Status: Active
Location: 6 locations
Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cysts
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
A Vaccine (Dendritic Cell 1) for the Treatment of Patients with HER-2 Positive Breast Cancer, NATASHA Study
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Anthracycline-Free Chemotherapy and Immunotherapy Regimen for the Treatment of Triple-Negative Breast Cancer Patients at Risk for Cardiotoxicity, NeoCARD Trial
Status: Active
Location: Medical University of South Carolina, Charleston, South Carolina